HR091506 tablets

HR091506 · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HR091506 tablets, covering 2024-05-16 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]